Cite
MLA Citation
Paula I Gonzalez‐Ericsson et al.. “The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice.” Journal of pathology, vol. 250, no. 5, 2020, pp. 667–684. http://access.bl.uk/ark:/81055/vdc_100102785869.0x00005e